Investors are on the edges of their seats, hoping that Silicon Laboratories
What analysts say:
- Buy, sell, or hold?: The majority of analysts back Silicon Laboratories as a buy. But with 54.5% of analysts rating it a buy, Silicon Laboratories is still below the mean analyst rating of its nearest 10 competitors, which average 68.9% buys. Analysts don't like Silicon Laboratories as much as competitor Semtech overall. Five out of five analysts rate Semtech a buy compared to six of 11 for Silicon Laboratories. Analysts' rating of Silicon Laboratories has stayed constant from three months prior.
- Revenue Forecasts: On average, analysts predict $119.8 million in revenue this quarter. That would represent a rise of 7.1% from the year-ago quarter.
- Wall Street Earnings Expectations: The average analyst estimate is earnings of $0.25 per share. Estimates range from $0.24 to $0.25.
What our community says:
CAPS All-Stars are solidly backing the stock with 97.8% awarding it an "outperform" rating. The community at large agrees with the All-Stars with 92.9% assigning it a rating of "outperform." Fools have embraced Silicon Laboratories, though the message boards have been quiet lately with only 94 posts in the past 30 days. Silicon Laboratories has a bullish CAPS rating of five out of five stars that is about on par with the Fool community assessment.
Management:
Revenue has fallen for the past three quarters. The company's gross margin shrank by 4.3 percentage points in the last quarter. Revenue fell 0.9% while cost of sales rose 11.4% to $46.2 million from a year earlier.
Quarter | Q3 | Q2 | Q1 | Q4 |
Gross Margin | 61.2% | 60.4% | 60.3% | 63.5% |
Operating Margin | 11.7% | 12.7% | 4.1% | 9.8% |
Net Margin | 9.5% | 10.6% | (1.6%) | 11.5% |
One final thing: If you want to keep tabs on Silicon Laboratories movements, and for more analysis on the company, make sure you add it to your Watchlist.